KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Depreciation and Depletion (2016 - 2020)

Historic Depreciation and Depletion for Palvella Therapeutics (PVLA) over the last 7 years, with Q2 2020 value amounting to $530000.0.

  • Palvella Therapeutics' Depreciation and Depletion rose 116190.48% to $530000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $1.3 million, marking a year-over-year increase of 13658.54%. This contributed to the annual value of $1.8 million for FY2023, which is 2173.91% down from last year.
  • As of Q2 2020, Palvella Therapeutics' Depreciation and Depletion stood at $530000.0, which was up 116190.48% from $339000.0 recorded in Q1 2020.
  • Over the past 5 years, Palvella Therapeutics' Depreciation and Depletion peaked at $530000.0 during Q2 2020, and registered a low of -$11764.0 during Q2 2016.
  • For the 5-year period, Palvella Therapeutics' Depreciation and Depletion averaged around $159388.9, with its median value being $133000.0 (2017).
  • As far as peak fluctuations go, Palvella Therapeutics' Depreciation and Depletion tumbled by 11539.03% in 2016, and later surged by 116190.48% in 2020.
  • Over the past 5 years, Palvella Therapeutics' Depreciation and Depletion (Quarter) stood at $224613.0 in 2016, then crashed by 41.23% to $132000.0 in 2017, then soared by 47.73% to $195000.0 in 2018, then grew by 19.49% to $233000.0 in 2019, then surged by 127.47% to $530000.0 in 2020.
  • Its last three reported values are $530000.0 in Q2 2020, $339000.0 for Q1 2020, and $233000.0 during Q4 2019.